Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07374107 · ClinicalTrials.gov registry record
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
A clinical trial of Dermatomyositis and Inclusion Body Myositis, sponsored by Myositis International Health & Research Collaborative Alliance Foundation.
- Recruiting
- Registry status
- 700
- Enrollment target
- 1
- Study location
NCT07374107: Recruiting study of Dermatomyositis and Inclusion Body Myositis, sponsored by Myositis International Health & Research Collaborative Alliance Foundation.
NCT07374107 is a study of Dermatomyositis and Inclusion Body Myositis that is actively recruiting participants, run by Myositis International Health & Research Collaborative Alliance Foundation. The registered enrollment target is 700 participants, above the 448-participant average among 19 other Dermatomyositis trials with a reported enrollment target (56% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07374107, a study of Dermatomyositis and Inclusion Body Myositis, is actively recruiting participants, sponsored by Myositis International Health & Research Collaborative Alliance Foundation.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly online) methods of open-ended questions, community forums and survey to identify the most pressing research concerns as identified by patients. Findings will be analyzed to create a patient-voiced set of research priorities that can guide the direction of research and help inform funding decisions across myositis diseases. Potential participants can express interest via https://mihrafoundation.org/mihra-programs/mihra-patient-contact-registry/
Primary Outcome
Number and distribution of coded priority domains identified from data collection that has been stratified by disease type, through thematic analysis (codebook refined iteratively) with subsequent assigned degree of importance and ranked priority.
Conditions Studied
Interventions
- OTHER No intervention - qualitative and mixed methods investigations
Study Locations (1)
Louisiana
- MIHRA Foundation - This is a GLOBAL STUDY - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2030-12 |
What NCT07374107 shows while recruiting
NCT07374107 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, above the 448-participant average among 19 other Dermatomyositis trials with a reported enrollment target (56% higher).
The record links to 10 conditions, with Dermatomyositis appearing as the primary indexed condition, and to 1 intervention - of which No intervention - qualitative and mixed methods investigations is the first listed.
NCT07374107 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07374107 about?
NCT07374107 is a clinical study titled "MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)". Myositis diseases are each rare diseases. As in other rare diseases, people living with myositis diseases face physical and psychosocial challenges that may not be recognized in current research priorities. The PRISMS study is a global investigation that collects patient perspectives through (mostly...
What is the current status of trial NCT07374107?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2025-06-25. Estimated completion is 2030-12.
What conditions does trial NCT07374107 study?
This clinical trial studies the following conditions: Dermatomyositis, Inclusion Body Myositis, Polymyositis, Myositis, Anti-Synthetase Syndrome.
What interventions are being tested in trial NCT07374107?
The interventions under investigation include: No intervention - qualitative and mixed methods investigations (OTHER).
Who is sponsoring clinical trial NCT07374107?
This trial is sponsored by Myositis International Health & Research Collaborative Alliance Foundation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07374107 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dermatomyositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07374107's enrollment target sits among peer trials
700 3rd of 19 higher than 17 of 19 other Dermatomyositis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dermatomyositis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
RECRUITING · Phase 3
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
RECRUITING
-
Adult and Juvenile Myositis
RECRUITING
-
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RECRUITING · Phase 2
-
Rheumatology Patient Registry and Biorepository
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI